UpHealth (UPH) PT Lowered to $10 at Oppenheimer
- Wall St slumps as investors fret on rate hikes and recession
- Think September Was Bad? Watch Out for 'Octoberphobia', Stock Trader's Almanac Warns
- Goldman Sachs Slashes Year-End Target on S&P 500 to 3,600
- Oil: The 'R'-Word Rules as U.S. Crude Below $80 for Worst Week in 7
- Bond Crash of 2022 is a 'Doozy' - BofA
Oppenheimer lowered its price target on UpHealth (NYSE: UPH) to $10.00 (from $12.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Compagnie Financiere Richemont SA (CFR:SW) (CFRUY) PT Raised to CHF128 at Goldman Sachs
- Sangoma Technologies Corporation (STC:CN) (SAMOF) PT Lowered to Cdn$18.50 at TD Securities
- Burberry Group PLC (BRBY:LN) (BBRYF) PT Raised to GBP24.10 at Goldman Sachs
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!